GMP Non-Compliance And Failed Acceptance in Cleanroom Construction Of Hollow Capsule Production Lines

Feb 12, 2026

Leave a message

GMP (Good Manufacturing Practice) compliance and successful acceptance are the prerequisites for the formal operation of hollow capsule production lines, as hollow capsules, as critical drug carriers, are subject to strict quality and safety supervision in accordance with pharmaceutical production standards. However, GMP non-compliance and failed acceptance have become common and critical problems in the construction of cleanrooms for hollow capsule production, often resulting in delayed production startup, increased transformation costs, and even inability to obtain production qualifications. The root causes of this problem are mainly the lack of necessary supporting facilities during the cleanroom construction stage and the failure to meet the specified standards for key inspection indicators during the final acceptance.

 

One of the main reasons for GMP non-compliance is the lack of necessary supporting facilities in the cleanroom design and construction process, which fails to meet the basic requirements of GMP for pharmaceutical clean production environments. These missing facilities mainly include cleanroom testing ports, differential pressure gauges, disinfection facilities, pass-through windows, and other key components that are closely related to the maintenance of clean environment and production compliance. Specifically, cleanroom testing ports are essential for regular detection of indoor cleanliness indicators (such as suspended particles, settling bacteria); the lack of reasonable layout or insufficient quantity of testing ports will make it impossible to accurately and comprehensively monitor the cleanliness of each functional area in the cleanroom, and also fail to meet the on-site inspection requirements of GMP auditors.

 

Differential pressure gauges are core equipment for monitoring the pressure difference between different functional areas of the cleanroom, which is crucial to preventing the diffusion of dust and microorganisms and avoiding cross-contamination. The lack of differential pressure gauges in key positions (such as between high-cleanliness and low-cleanliness areas) or the incorrect installation of differential pressure gauges will lead to the inability to effectively monitor the pressure difference status of the cleanroom, making it impossible to timely find and solve the problem of pressure difference failure, which directly violates the GMP requirements for cleanroom pressure difference control. In addition, the lack of necessary disinfection facilities (such as ultraviolet disinfection lamps, ozone disinfection equipment, or automatic disinfection systems) will result in the inability to effectively kill microorganisms in the cleanroom, leading to excessive microbial indicators and failing to meet the GMP requirements for a sterile and clean production environment.

 

Pass-through windows, as important equipment for realizing the separation of people and logistics and avoiding cross-contamination between different clean areas, are also often missing or improperly designed in some cleanroom constructions. The lack of pass-through windows will force operators to pass through high-cleanliness areas when transferring materials or tools, which will easily bring dust and microorganisms into the high-cleanliness production area; even if pass-through windows are installed, improper design (such as insufficient airtightness, unreasonable size, or lack of self-cleaning functions) will also fail to play the role of isolation and protection, thus affecting GMP compliance.

 

On the other hand, the failure to meet the standards for key inspection indicators during the final acceptance of the cleanroom is another direct reason for failing to pass GMP certification or on-site audits. According to GMP requirements and relevant national standards for hollow capsule production, the cleanroom must pass strict detection of multiple indicators during acceptance, among which suspended particles, settling bacteria, and air change rate are the three core indicators that directly determine the qualification of the cleanroom. Suspended particles are an important indicator reflecting the cleanliness level of the cleanroom; excessive suspended particles will adhere to the surface of the capsule shell, affecting the cleanliness and quality of the product. During the acceptance process, if the number of suspended particles (especially particles with a particle size of 0.5μm and 5.0μm) in each functional area exceeds the specified limit of the corresponding cleanliness level (such as 100,000-level or 10,000-level), the acceptance will be deemed unqualified.

 

Settling bacteria are key indicators reflecting the microbial contamination status of the cleanroom. Excessive settling bacteria will easily cause microbial contamination of the capsule shell, bringing potential safety hazards to the subsequent drug filling. During the acceptance test, if the number of settling bacteria in the production area (especially the forming and packaging areas) exceeds the specified standard, it will directly lead to acceptance failure. The air change rate, as an important guarantee for maintaining the cleanliness and stability of the cleanroom environment, directly affects the effect of removing dust and microorganisms in the room. If the air change rate is too low, it will be impossible to timely discharge pollutants in the room, resulting in the accumulation of dust and microorganisms; if the air change rate is unstable, it will cause fluctuations in temperature, humidity and cleanliness, all of which will lead to the failure of the air change rate indicator to meet the standard during acceptance.

 

It should be emphasized that the consequences of GMP non-compliance and failed acceptance are extremely serious. Once the cleanroom fails to pass GMP certification or on-site audit, the production line cannot be put into formal production. Enterprises need to carry out comprehensive transformation and rectification of the cleanroom, including adding missing facilities, adjusting the ventilation and air conditioning system, and optimizing the clean control measures, which will not only increase a lot of additional transformation costs, but also delay the production startup cycle and cause economic losses. In addition, repeated failure to pass GMP certification will also affect the enterprise's credibility and market access qualifications.

 

In conclusion, GMP non-compliance and failed acceptance in the construction of cleanrooms for hollow capsule production lines are mainly caused by the lack of necessary supporting facilities (such as cleanroom testing ports, differential pressure gauges, disinfection facilities, pass-through windows, etc.) and the failure of key inspection indicators (suspended particles, settling bacteria, air change rate, etc.) to meet the standards during acceptance. To solve this problem, enterprises must fully implement GMP requirements in the early design and construction stage of the cleanroom, reasonably configure all necessary supporting facilities, strictly control the construction quality, and conduct pre-acceptance and self-inspection in advance according to the acceptance standards, so as to ensure that the cleanroom can pass GMP certification and on-site audit smoothly and lay a solid foundation for the formal production of hollow capsules.